TCBP: TC BioPharm Company Cash Volume

Public company logo of tcbiopharm.com (TCBP)

The high potential of TC Biopharm (TCBP) is driven by the creation of universal cell-based therapies available to patients instantaneously. The cash reserve history visualizes liquidity dynamics, where 0.00 determines the latest valuation metric. The company's growth relies on the development of leukemia therapy and FDA support, while its scaling strategy is based on alliances with oncology centers without utilizing mergers.

Company Cash Reserve: TC BioPharm (Holdings) PLC (TCBP) for 04/28/2023 - 03/29/2025

Financial and market metric breakdowns for TC BioPharm (TCBP)

- stock quotes and analyst forecast:
Comprehensive company analysis:TCBP TC Biopharm
Brand item of tcbiopharm.com

The status of the British developer within a secure Western perimeter minimizes external risks for TC Biopharm. Analyzing current cash levels, the investor assesses the liquidity required to sustain scientific activities. This metric measures the volume of available capital, preventing cash flow gaps as borrowing costs rise. An optimal balance of funds ensures financial autonomy without sacrificing development momentum. A sufficient cash reserve guarantees the preservation of patents and research.

Direct competitors

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|CLDX: Company Cash Balance|Company Cash Funds Aurinia Pharmaceuticals Inc. (AUPH)|Company Cash Funds BCRX (BioCryst Pharmaceuticals Inc)|Company Cash Volume VERA (Vera Corp)|Company Total Cash Amount DNTH (Dianthus Therapeutics)|PHVS - Company Cash Funds|ABCL: Company Cash Funds|TRML: Company Cash Volume|Company Cash on Hand Precigen, Inc.|Company Cash on Hand PHAR|Nektar Therapeutics - Company Total Cash Volume|Company Cash Funds Upstream Bio Corp (UPB)|Company Cash on Hand Zenas Biopharma ZBIO|Company Cash Funds Immunome Bio IMNM|GOSS: Company Cash and Cash Equivalents|kalvista.com - Company Cash Volume|SEPN (septerna.com) - Company Cash and Cash Equivalents|PVLA (Pieris Pharmaceuticals) - Company Cash on Hand|Savara - Company Cash Balance|RIGL (Rigel Corp) - Company Cash Volume|Company Cash Volume AnaptysBio Corp|Company Cash Funds astriatx.com (ATXS)|Company Cash on Hand enGene ENGN|Company Cash Funds RAPT Therapeutics, Inc. RAPT|JBIO - Company Cash on Hand|Aclaris Therapeutics Inc. - Company Cash Volume|KYTX - Company Cash Volume|TLSA (Tiziana Life Sciences PLC) - Company Cash on Hand|cabalettabio.com (CABA) - Company Cash Volume|Company Cash Funds Ventyx Biosciences|THTX (Theratechnologies) - Company Total Cash Amount|Company Cash on Hand AVTX (Avalo Therapeutics Inc.)|Company Cash Funds ELDN (Eledon)|Company Cash Volume AGEN (Agenus, Inc)|Company Liquid Assets climbbio.com (CLYM)|zurabio.com - Company Cash Volume|ATYR - Company Cash Volume|ADAG: Company Cash Volume|Ikena Oncology, Inc. (IMA) - Company Cash Volume|STTK (Shattuck Therapeutics) - Company Cash Volume|Company Cash Reserve equilliumbio.com EQ|Company Cash Volume CNTB|IMUX - Company Cash Reserve|Company Cash Funds Atara Biotherapeutics ATRA|Company Liquid Assets InflaRx N.V. (IFRX)|XFOR: Company Cash on Hand|adicetbio.com (ACET) - Company Cash on Hand|CELU: Company Cash Volume|Company Cash Reserve INmune Bio (INMB)|Company Cash Funds Barinthus Bio|Company Cash and Cash Equivalents KZR (Kezar Life Sciences, Inc)|Company Cash on Hand SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Company Cash and Cash Equivalents|Enlivex Therapeutics Ltd - Company Cash on Hand|Company Cash Balance QTTB|GOVX - Company Cash Funds|Company Cash Reserve Edesa|IBIO: Company Cash Volume|Company Cash Reserve Carisma Therapeutics Inc (CARM)|Company Cash Funds XTL Biopharmaceuticals, Ltd.|Company Cash Funds BOLT|Company Cash on Hand HCWB (HCW Biologics, Inc.)|Company Total Cash Amount APVO|AIM ImmunoTech - Company Cash on Hand|Company Cash Balance ADTX|GRI - Company Cash Funds|XRTX (XORTX Therapeutics Inc) - Company Cash and Cash Equivalents|HIND: Company Cash Volume|REVB (Revelation Bio) - Company Cash Funds|Company Cash Funds Indaptus|Scinai Immunotherapeutics (SCNI) - Company Liquid Assets|Company Cash Volume CALI|Company Cash on Hand Affimed NV AFMD|Company Cash Funds Allakos Inc ALLK|HOOK (HOOKIPA) - Company Total Cash Volume|IGM Biosciences - Company Cash Volume|ITOS - Company Cash Volume|Ocean Biomedical Corp (OCEA) - Company Cash Funds|Company Cash and Cash Equivalents THRD